Toma N M, Hungerford J L, Plowman P N, Kingston J E, Doughty D
Department of Ophthalmology, St Bartholomew's Hospital, London.
Br J Ophthalmol. 1995 Feb;79(2):112-7. doi: 10.1136/bjo.79.2.112.
A retrospective analysis is presented of the results of external beam radiotherapy for retinoblastoma utilising an accurate lens sparing technique. Local tumour control has been assessed in a consecutive series of 67 eyes in 53 children all of whom received external beam radiotherapy as the primary treatment of retinoblastoma. Follow up ranged from 12 to 82 months (median 35 months) with 76% of the children followed for more than 2 years. Tumour control rates have been analysed with respect to the Reese-Ellsworth classification. The role of adjuvant and salvage focal therapy is emphasised. Following lens sparing radiotherapy with prior adjuvant treatment of anterior tumours, where appropriate, the overall ocular cure rate was 72%. With salvage therapy of persistent, recurrent, or new tumours, 93% of eyes could be preserved in this series which includes mainly eyes classified in Reese-Ellsworth groups I-III. These results compare favourably with those of whole eye external beam radiotherapy for comparable tumours, and with those of lens and anterior segment sparing using other techniques. They were achieved without the ocular morbidity associated with whole eye external beam radiotherapy.
本文对利用精确的晶状体保留技术进行视网膜母细胞瘤外照射放疗的结果进行了回顾性分析。对53名儿童的67只眼睛进行了连续评估,所有这些儿童均接受外照射放疗作为视网膜母细胞瘤的主要治疗方法。随访时间为12至82个月(中位时间35个月),76%的儿童随访时间超过2年。已根据里斯-埃尔斯沃思分类法分析了肿瘤控制率。强调了辅助和挽救性局部治疗的作用。在对前部肿瘤进行适当的辅助治疗后进行晶状体保留放疗,总体眼部治愈率为72%。在本系列中,通过对持续性、复发性或新发性肿瘤进行挽救性治疗,93%的眼睛得以保留,该系列主要包括里斯-埃尔斯沃思分类为I-III组的眼睛。这些结果与对类似肿瘤进行全眼球外照射放疗的结果以及使用其他技术进行晶状体和前段保留放疗的结果相比具有优势。在没有全眼球外照射放疗相关眼部并发症的情况下取得了这些结果。